Review




Structured Review

Servicebio Inc cell nuclei with dapi
CircATXN2 is upregulated in PAH models and hypoxic PASMCs A Right ventricular systolic pressure (RVSP) measured by invasive catheterization in control (Ctrl, normoxia) and Su-Hyp-induced PAH (PAH) mice ( n = 6). B , C Volcano plot (B) and Heatmap (C) of differentially expressed circRNAs from RNA-seq analysis of lung tissue from Ctrl and PAH mice (fold change (> 2 or < 0.5), P < 0.05). D qRT-PCR analysis of circATXN2 expression in primary mouse pulmonary artery endothelial cells (PAECs) versus pulmonary artery smooth muscle cells (PASMCs) ( n = 3). E qRT-PCR analysis of circATXN2 expression in PASMCs exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2 for 24 h) ( n = 3) F RT-PCR validation of circATXN2 in PASMCs using divergent primers (amplifying circATXN2) and convergent primers (amplifying linear ATXN2 mRNA) with cDNA and genomic DNA (gDNA) templates. 18S was used as a positive control for both templates. G qRT-PCR analysis of circATXN2 and linear ATXN2 mRNA levels in PASMCs treated with RNase R or a mock control ( n = 3). H Schematic and Sanger sequencing validation of the back-splicing junction (BSJ) of circATXN2, confirming its origin from exons 18 and 19. I Fluorescence in situ hybridization (FISH) of circATXN2 (red) and 18S (green) in PASMCs, demonstrating primary cytoplasmic localization. Nuclei were counterstained <t>with</t> <t>DAPI</t> (blue). Scale bar: 50 µm. J RT-PCR analysis of the distribution of circATXN2 in diverse organs. K Conservation analysis of the circATXN2 sequence in different species. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 , ****P < 0.0001, ns , not significant
Cell Nuclei With Dapi, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell nuclei with dapi/product/Servicebio Inc
Average 86 stars, based on 1 article reviews
cell nuclei with dapi - by Bioz Stars, 2026-06
86/100 stars

Images

1) Product Images from "CircATXN2 exacerbates pulmonary arterial hypertension by modulating the miR-138-5p/SMURF1 axis"

Article Title: CircATXN2 exacerbates pulmonary arterial hypertension by modulating the miR-138-5p/SMURF1 axis

Journal: Respiratory Research

doi: 10.1186/s12931-026-03647-w

CircATXN2 is upregulated in PAH models and hypoxic PASMCs A Right ventricular systolic pressure (RVSP) measured by invasive catheterization in control (Ctrl, normoxia) and Su-Hyp-induced PAH (PAH) mice ( n = 6). B , C Volcano plot (B) and Heatmap (C) of differentially expressed circRNAs from RNA-seq analysis of lung tissue from Ctrl and PAH mice (fold change (> 2 or < 0.5), P < 0.05). D qRT-PCR analysis of circATXN2 expression in primary mouse pulmonary artery endothelial cells (PAECs) versus pulmonary artery smooth muscle cells (PASMCs) ( n = 3). E qRT-PCR analysis of circATXN2 expression in PASMCs exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2 for 24 h) ( n = 3) F RT-PCR validation of circATXN2 in PASMCs using divergent primers (amplifying circATXN2) and convergent primers (amplifying linear ATXN2 mRNA) with cDNA and genomic DNA (gDNA) templates. 18S was used as a positive control for both templates. G qRT-PCR analysis of circATXN2 and linear ATXN2 mRNA levels in PASMCs treated with RNase R or a mock control ( n = 3). H Schematic and Sanger sequencing validation of the back-splicing junction (BSJ) of circATXN2, confirming its origin from exons 18 and 19. I Fluorescence in situ hybridization (FISH) of circATXN2 (red) and 18S (green) in PASMCs, demonstrating primary cytoplasmic localization. Nuclei were counterstained with DAPI (blue). Scale bar: 50 µm. J RT-PCR analysis of the distribution of circATXN2 in diverse organs. K Conservation analysis of the circATXN2 sequence in different species. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 , ****P < 0.0001, ns , not significant
Figure Legend Snippet: CircATXN2 is upregulated in PAH models and hypoxic PASMCs A Right ventricular systolic pressure (RVSP) measured by invasive catheterization in control (Ctrl, normoxia) and Su-Hyp-induced PAH (PAH) mice ( n = 6). B , C Volcano plot (B) and Heatmap (C) of differentially expressed circRNAs from RNA-seq analysis of lung tissue from Ctrl and PAH mice (fold change (> 2 or < 0.5), P < 0.05). D qRT-PCR analysis of circATXN2 expression in primary mouse pulmonary artery endothelial cells (PAECs) versus pulmonary artery smooth muscle cells (PASMCs) ( n = 3). E qRT-PCR analysis of circATXN2 expression in PASMCs exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2 for 24 h) ( n = 3) F RT-PCR validation of circATXN2 in PASMCs using divergent primers (amplifying circATXN2) and convergent primers (amplifying linear ATXN2 mRNA) with cDNA and genomic DNA (gDNA) templates. 18S was used as a positive control for both templates. G qRT-PCR analysis of circATXN2 and linear ATXN2 mRNA levels in PASMCs treated with RNase R or a mock control ( n = 3). H Schematic and Sanger sequencing validation of the back-splicing junction (BSJ) of circATXN2, confirming its origin from exons 18 and 19. I Fluorescence in situ hybridization (FISH) of circATXN2 (red) and 18S (green) in PASMCs, demonstrating primary cytoplasmic localization. Nuclei were counterstained with DAPI (blue). Scale bar: 50 µm. J RT-PCR analysis of the distribution of circATXN2 in diverse organs. K Conservation analysis of the circATXN2 sequence in different species. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 , ****P < 0.0001, ns , not significant

Techniques Used: Control, RNA Sequencing, Quantitative RT-PCR, Expressing, Reverse Transcription Polymerase Chain Reaction, Biomarker Discovery, Positive Control, Sequencing, Fluorescence, In Situ Hybridization

CircATXN2 knockdown alleviates hypoxia-induced PASMC proliferation and migration. PASMCs were transfected with a negative control siRNA (si-NC) or an siRNA targeting circATXN2 (si-circATXN2) for 24 h. Cells were then exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2) for an additional 24 h. A Viability measured by Cell Count Kit-8 (CCK-8) assays with transfected with si-circATXN2 ( n = 5) B , E Representative images ( B ) and quantification ( E ) of cell proliferation assessed by EdU incorporation. EdU-positive (proliferating) cells are green; nuclei are counterstained with DAPI (blue) ( n = 6). Scale bar: 100 µm. C , F Representative images ( C ) and quantification ( F ) of cell migration assessed by a wound healing assay. Images were captured at 0 h and 24 h post-scratch ( n = 5). Scale bar: 100 µm. D , G Representative images ( D ) and quantification ( G ) of cell migration assessed by a Transwell assay. Migrated cells were stained with crystal violet ( n = 5). Scale bar: 50 µm. All data are presented as the mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey's post-hoc test. * P < 0.05, **P < 0.01, ***P < 0.001, ns , not significant
Figure Legend Snippet: CircATXN2 knockdown alleviates hypoxia-induced PASMC proliferation and migration. PASMCs were transfected with a negative control siRNA (si-NC) or an siRNA targeting circATXN2 (si-circATXN2) for 24 h. Cells were then exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2) for an additional 24 h. A Viability measured by Cell Count Kit-8 (CCK-8) assays with transfected with si-circATXN2 ( n = 5) B , E Representative images ( B ) and quantification ( E ) of cell proliferation assessed by EdU incorporation. EdU-positive (proliferating) cells are green; nuclei are counterstained with DAPI (blue) ( n = 6). Scale bar: 100 µm. C , F Representative images ( C ) and quantification ( F ) of cell migration assessed by a wound healing assay. Images were captured at 0 h and 24 h post-scratch ( n = 5). Scale bar: 100 µm. D , G Representative images ( D ) and quantification ( G ) of cell migration assessed by a Transwell assay. Migrated cells were stained with crystal violet ( n = 5). Scale bar: 50 µm. All data are presented as the mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey's post-hoc test. * P < 0.05, **P < 0.01, ***P < 0.001, ns , not significant

Techniques Used: Knockdown, Migration, Transfection, Negative Control, Cell Characterization, CCK-8 Assay, Wound Healing Assay, Transwell Assay, Staining

circATXN2 acting as a miR-138-5p sponge. A RNA Immunoprecipitation (RIP) for AGO2. qRT-PCR shows significant enrichment of circATXN2 in AGO2 pulldowns compared to IgG controls in PASMCs ( n = 3). B Venn diagram of predicted miRNA targets for circATXN2 from miRanda, TargetScan, and RNAhybrid, identifying miR-138-5p as a top candidate. C RNA pulldown assay using biotinylated miR-138-5p or other candidate miRNAs identified in (B). qRT-PCR analysis shows specific and significant enrichment of circATXN2 only with the miR-138-5p probe ( n = 3). D Schematic of circATXN2 (318 nt) showing the 6 predicted binding sites for miR-138-5p. E Co-localization of circATXN2 (red) and miR-138-5p (green) in PASMCs via FISH assays, demonstrating co-localization in the cytoplasm. Nuclei are counterstained with DAPI (blue). Scale bar: 50 µm. F , G qRT-PCR analysis of miR-138-5p levels in PASMCs following (F) knockdown of circATXN2 (si-circATXN2) or (G) overexpression of circATXN2 (oe-circATXN2), demonstrating reciprocal regulation ( n = 3). H-M Functional rescue experiments. PASMCs were co-transfected with a miR-138-5p mimic or negative control (miR-NC), along with an overexpression vector for circATXN2 (oe-circATXN2) or its control (oe-NC). CCK-8 viability assay ( n = 5) (H). Representative images (I) and quantification (K) of EdU proliferation assay ( n = 3). Scale bar: 100 µm. Representative images (J) and quantification (M) of Transwell migration assay ( n = 3). Scale bar: 50 µm. Quantification of wound healing migration assay ( n = 3) (L). The miR-138-5p mimic reversed the pro-proliferative and pro-migratory effects of circATXN2 overexpression. All data are presented as the mean ± SEM. Statistical significance was determined using a two-tailed Student's t-test (for A, C, F, G) or one-way ANOVA followed by Tukey's post-hoc test (for H, K, L, M). * P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns , not significant
Figure Legend Snippet: circATXN2 acting as a miR-138-5p sponge. A RNA Immunoprecipitation (RIP) for AGO2. qRT-PCR shows significant enrichment of circATXN2 in AGO2 pulldowns compared to IgG controls in PASMCs ( n = 3). B Venn diagram of predicted miRNA targets for circATXN2 from miRanda, TargetScan, and RNAhybrid, identifying miR-138-5p as a top candidate. C RNA pulldown assay using biotinylated miR-138-5p or other candidate miRNAs identified in (B). qRT-PCR analysis shows specific and significant enrichment of circATXN2 only with the miR-138-5p probe ( n = 3). D Schematic of circATXN2 (318 nt) showing the 6 predicted binding sites for miR-138-5p. E Co-localization of circATXN2 (red) and miR-138-5p (green) in PASMCs via FISH assays, demonstrating co-localization in the cytoplasm. Nuclei are counterstained with DAPI (blue). Scale bar: 50 µm. F , G qRT-PCR analysis of miR-138-5p levels in PASMCs following (F) knockdown of circATXN2 (si-circATXN2) or (G) overexpression of circATXN2 (oe-circATXN2), demonstrating reciprocal regulation ( n = 3). H-M Functional rescue experiments. PASMCs were co-transfected with a miR-138-5p mimic or negative control (miR-NC), along with an overexpression vector for circATXN2 (oe-circATXN2) or its control (oe-NC). CCK-8 viability assay ( n = 5) (H). Representative images (I) and quantification (K) of EdU proliferation assay ( n = 3). Scale bar: 100 µm. Representative images (J) and quantification (M) of Transwell migration assay ( n = 3). Scale bar: 50 µm. Quantification of wound healing migration assay ( n = 3) (L). The miR-138-5p mimic reversed the pro-proliferative and pro-migratory effects of circATXN2 overexpression. All data are presented as the mean ± SEM. Statistical significance was determined using a two-tailed Student's t-test (for A, C, F, G) or one-way ANOVA followed by Tukey's post-hoc test (for H, K, L, M). * P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns , not significant

Techniques Used: RNA Immunoprecipitation, Quantitative RT-PCR, Binding Assay, Knockdown, Over Expression, Functional Assay, Transfection, Negative Control, Plasmid Preparation, Control, CCK-8 Assay, Viability Assay, Proliferation Assay, Transwell Migration Assay, Migration, Two Tailed Test

Reducing circATXN2 in SMCs attenuated the severity of PAH via miR-138-5p/SMURF1 axis. A Immunofluorescence staining of pulmonary arteries confirming SMC-specific AAV9 transduction. GFP (AAV9, green) co-localizes with the SMC marker α-SMA (red). Nuclei were counterstained with DAPI (blue). Scale bar: 100 µm. B qRT-PCR analysis of circATXN2 expression in lung tissue from mice injected with AAV9-si-NC or AAV9-si-circATXN2, confirming successful knockdown ( n = 6) . C Quantification of Right Ventricular Systolic Pressure (RVSP) in the four treatment groups ( n = 6). D , E Echocardiographic measurements of AT/ET ratio (D) and PAVTI (E) in the four treatment groups ( n = 6). F , G Quantification (F) and Hematoxylin and Eosin (H&E) staining (G) of pulmonary arterioles, showing reduced medial wall thickening in the AAV9-si-circATXN2-treated hypoxia group ( n = 6). Scale bar: 50 µm. H Western blot analysis of SMURF1 protein expression in lung lysates from the four treatment groups. β-actin was used as a loading control ( n = 6). I To validate the in vivo role of circATXN2, SMC-specific knockdown was achieved using AAV9-si-circATXN2 in 6-week-old Tagln-Cre mice. As shown in the schematic, mice were injected via the tail vein. After a two-week infection period, mice were exposed to normoxia (21% FiO 2 ) or chronic hypoxia (10% FiO 2 ) and weekly subcutaneous semaxanib (SU5416, 20 mg/kg/week) injections for 4 weeks to induce PAH. All data are presented as the mean ± SEM. Statistical significance was determined using a two-tailed Student's t-test (for B) or two-way ANOVA followed by Tukey's post-hoc test (for C-F). * P < 0.05, **P < 0.01, ns , not significant
Figure Legend Snippet: Reducing circATXN2 in SMCs attenuated the severity of PAH via miR-138-5p/SMURF1 axis. A Immunofluorescence staining of pulmonary arteries confirming SMC-specific AAV9 transduction. GFP (AAV9, green) co-localizes with the SMC marker α-SMA (red). Nuclei were counterstained with DAPI (blue). Scale bar: 100 µm. B qRT-PCR analysis of circATXN2 expression in lung tissue from mice injected with AAV9-si-NC or AAV9-si-circATXN2, confirming successful knockdown ( n = 6) . C Quantification of Right Ventricular Systolic Pressure (RVSP) in the four treatment groups ( n = 6). D , E Echocardiographic measurements of AT/ET ratio (D) and PAVTI (E) in the four treatment groups ( n = 6). F , G Quantification (F) and Hematoxylin and Eosin (H&E) staining (G) of pulmonary arterioles, showing reduced medial wall thickening in the AAV9-si-circATXN2-treated hypoxia group ( n = 6). Scale bar: 50 µm. H Western blot analysis of SMURF1 protein expression in lung lysates from the four treatment groups. β-actin was used as a loading control ( n = 6). I To validate the in vivo role of circATXN2, SMC-specific knockdown was achieved using AAV9-si-circATXN2 in 6-week-old Tagln-Cre mice. As shown in the schematic, mice were injected via the tail vein. After a two-week infection period, mice were exposed to normoxia (21% FiO 2 ) or chronic hypoxia (10% FiO 2 ) and weekly subcutaneous semaxanib (SU5416, 20 mg/kg/week) injections for 4 weeks to induce PAH. All data are presented as the mean ± SEM. Statistical significance was determined using a two-tailed Student's t-test (for B) or two-way ANOVA followed by Tukey's post-hoc test (for C-F). * P < 0.05, **P < 0.01, ns , not significant

Techniques Used: Immunofluorescence, Staining, Transduction, Marker, Quantitative RT-PCR, Expressing, Injection, Knockdown, Western Blot, Control, In Vivo, Infection, Two Tailed Test



Similar Products

99
Sony Biotechnology single dapi nuclei
Single Dapi Nuclei, supplied by Sony Biotechnology, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single dapi nuclei/product/Sony Biotechnology
Average 99 stars, based on 1 article reviews
single dapi nuclei - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

98
Vector Laboratories stain cell nuclei
Stain Cell Nuclei, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stain cell nuclei/product/Vector Laboratories
Average 98 stars, based on 1 article reviews
stain cell nuclei - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

86
Servicebio Inc cell nuclei with dapi
CircATXN2 is upregulated in PAH models and hypoxic PASMCs A Right ventricular systolic pressure (RVSP) measured by invasive catheterization in control (Ctrl, normoxia) and Su-Hyp-induced PAH (PAH) mice ( n = 6). B , C Volcano plot (B) and Heatmap (C) of differentially expressed circRNAs from RNA-seq analysis of lung tissue from Ctrl and PAH mice (fold change (> 2 or < 0.5), P < 0.05). D qRT-PCR analysis of circATXN2 expression in primary mouse pulmonary artery endothelial cells (PAECs) versus pulmonary artery smooth muscle cells (PASMCs) ( n = 3). E qRT-PCR analysis of circATXN2 expression in PASMCs exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2 for 24 h) ( n = 3) F RT-PCR validation of circATXN2 in PASMCs using divergent primers (amplifying circATXN2) and convergent primers (amplifying linear ATXN2 mRNA) with cDNA and genomic DNA (gDNA) templates. 18S was used as a positive control for both templates. G qRT-PCR analysis of circATXN2 and linear ATXN2 mRNA levels in PASMCs treated with RNase R or a mock control ( n = 3). H Schematic and Sanger sequencing validation of the back-splicing junction (BSJ) of circATXN2, confirming its origin from exons 18 and 19. I Fluorescence in situ hybridization (FISH) of circATXN2 (red) and 18S (green) in PASMCs, demonstrating primary cytoplasmic localization. Nuclei were counterstained <t>with</t> <t>DAPI</t> (blue). Scale bar: 50 µm. J RT-PCR analysis of the distribution of circATXN2 in diverse organs. K Conservation analysis of the circATXN2 sequence in different species. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 , ****P < 0.0001, ns , not significant
Cell Nuclei With Dapi, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell nuclei with dapi/product/Servicebio Inc
Average 86 stars, based on 1 article reviews
cell nuclei with dapi - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

99
Beyotime stain cell nuclei with dapi
CircATXN2 is upregulated in PAH models and hypoxic PASMCs A Right ventricular systolic pressure (RVSP) measured by invasive catheterization in control (Ctrl, normoxia) and Su-Hyp-induced PAH (PAH) mice ( n = 6). B , C Volcano plot (B) and Heatmap (C) of differentially expressed circRNAs from RNA-seq analysis of lung tissue from Ctrl and PAH mice (fold change (> 2 or < 0.5), P < 0.05). D qRT-PCR analysis of circATXN2 expression in primary mouse pulmonary artery endothelial cells (PAECs) versus pulmonary artery smooth muscle cells (PASMCs) ( n = 3). E qRT-PCR analysis of circATXN2 expression in PASMCs exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2 for 24 h) ( n = 3) F RT-PCR validation of circATXN2 in PASMCs using divergent primers (amplifying circATXN2) and convergent primers (amplifying linear ATXN2 mRNA) with cDNA and genomic DNA (gDNA) templates. 18S was used as a positive control for both templates. G qRT-PCR analysis of circATXN2 and linear ATXN2 mRNA levels in PASMCs treated with RNase R or a mock control ( n = 3). H Schematic and Sanger sequencing validation of the back-splicing junction (BSJ) of circATXN2, confirming its origin from exons 18 and 19. I Fluorescence in situ hybridization (FISH) of circATXN2 (red) and 18S (green) in PASMCs, demonstrating primary cytoplasmic localization. Nuclei were counterstained <t>with</t> <t>DAPI</t> (blue). Scale bar: 50 µm. J RT-PCR analysis of the distribution of circATXN2 in diverse organs. K Conservation analysis of the circATXN2 sequence in different species. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 , ****P < 0.0001, ns , not significant
Stain Cell Nuclei With Dapi, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stain cell nuclei with dapi/product/Beyotime
Average 99 stars, based on 1 article reviews
stain cell nuclei with dapi - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

99
Beyotime cell nuclei
CircATXN2 is upregulated in PAH models and hypoxic PASMCs A Right ventricular systolic pressure (RVSP) measured by invasive catheterization in control (Ctrl, normoxia) and Su-Hyp-induced PAH (PAH) mice ( n = 6). B , C Volcano plot (B) and Heatmap (C) of differentially expressed circRNAs from RNA-seq analysis of lung tissue from Ctrl and PAH mice (fold change (> 2 or < 0.5), P < 0.05). D qRT-PCR analysis of circATXN2 expression in primary mouse pulmonary artery endothelial cells (PAECs) versus pulmonary artery smooth muscle cells (PASMCs) ( n = 3). E qRT-PCR analysis of circATXN2 expression in PASMCs exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2 for 24 h) ( n = 3) F RT-PCR validation of circATXN2 in PASMCs using divergent primers (amplifying circATXN2) and convergent primers (amplifying linear ATXN2 mRNA) with cDNA and genomic DNA (gDNA) templates. 18S was used as a positive control for both templates. G qRT-PCR analysis of circATXN2 and linear ATXN2 mRNA levels in PASMCs treated with RNase R or a mock control ( n = 3). H Schematic and Sanger sequencing validation of the back-splicing junction (BSJ) of circATXN2, confirming its origin from exons 18 and 19. I Fluorescence in situ hybridization (FISH) of circATXN2 (red) and 18S (green) in PASMCs, demonstrating primary cytoplasmic localization. Nuclei were counterstained <t>with</t> <t>DAPI</t> (blue). Scale bar: 50 µm. J RT-PCR analysis of the distribution of circATXN2 in diverse organs. K Conservation analysis of the circATXN2 sequence in different species. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 , ****P < 0.0001, ns , not significant
Cell Nuclei, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell nuclei/product/Beyotime
Average 99 stars, based on 1 article reviews
cell nuclei - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

Image Search Results


CircATXN2 is upregulated in PAH models and hypoxic PASMCs A Right ventricular systolic pressure (RVSP) measured by invasive catheterization in control (Ctrl, normoxia) and Su-Hyp-induced PAH (PAH) mice ( n = 6). B , C Volcano plot (B) and Heatmap (C) of differentially expressed circRNAs from RNA-seq analysis of lung tissue from Ctrl and PAH mice (fold change (> 2 or < 0.5), P < 0.05). D qRT-PCR analysis of circATXN2 expression in primary mouse pulmonary artery endothelial cells (PAECs) versus pulmonary artery smooth muscle cells (PASMCs) ( n = 3). E qRT-PCR analysis of circATXN2 expression in PASMCs exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2 for 24 h) ( n = 3) F RT-PCR validation of circATXN2 in PASMCs using divergent primers (amplifying circATXN2) and convergent primers (amplifying linear ATXN2 mRNA) with cDNA and genomic DNA (gDNA) templates. 18S was used as a positive control for both templates. G qRT-PCR analysis of circATXN2 and linear ATXN2 mRNA levels in PASMCs treated with RNase R or a mock control ( n = 3). H Schematic and Sanger sequencing validation of the back-splicing junction (BSJ) of circATXN2, confirming its origin from exons 18 and 19. I Fluorescence in situ hybridization (FISH) of circATXN2 (red) and 18S (green) in PASMCs, demonstrating primary cytoplasmic localization. Nuclei were counterstained with DAPI (blue). Scale bar: 50 µm. J RT-PCR analysis of the distribution of circATXN2 in diverse organs. K Conservation analysis of the circATXN2 sequence in different species. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 , ****P < 0.0001, ns , not significant

Journal: Respiratory Research

Article Title: CircATXN2 exacerbates pulmonary arterial hypertension by modulating the miR-138-5p/SMURF1 axis

doi: 10.1186/s12931-026-03647-w

Figure Lengend Snippet: CircATXN2 is upregulated in PAH models and hypoxic PASMCs A Right ventricular systolic pressure (RVSP) measured by invasive catheterization in control (Ctrl, normoxia) and Su-Hyp-induced PAH (PAH) mice ( n = 6). B , C Volcano plot (B) and Heatmap (C) of differentially expressed circRNAs from RNA-seq analysis of lung tissue from Ctrl and PAH mice (fold change (> 2 or < 0.5), P < 0.05). D qRT-PCR analysis of circATXN2 expression in primary mouse pulmonary artery endothelial cells (PAECs) versus pulmonary artery smooth muscle cells (PASMCs) ( n = 3). E qRT-PCR analysis of circATXN2 expression in PASMCs exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2 for 24 h) ( n = 3) F RT-PCR validation of circATXN2 in PASMCs using divergent primers (amplifying circATXN2) and convergent primers (amplifying linear ATXN2 mRNA) with cDNA and genomic DNA (gDNA) templates. 18S was used as a positive control for both templates. G qRT-PCR analysis of circATXN2 and linear ATXN2 mRNA levels in PASMCs treated with RNase R or a mock control ( n = 3). H Schematic and Sanger sequencing validation of the back-splicing junction (BSJ) of circATXN2, confirming its origin from exons 18 and 19. I Fluorescence in situ hybridization (FISH) of circATXN2 (red) and 18S (green) in PASMCs, demonstrating primary cytoplasmic localization. Nuclei were counterstained with DAPI (blue). Scale bar: 50 µm. J RT-PCR analysis of the distribution of circATXN2 in diverse organs. K Conservation analysis of the circATXN2 sequence in different species. All data are presented as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 , ****P < 0.0001, ns , not significant

Article Snippet: After washing with PBS, the sections were incubated with a Cy3-conjugated anti-rabbit at RT for 1 h, followed by labeling the cell nuclei with DAPI (Servicebio).

Techniques: Control, RNA Sequencing, Quantitative RT-PCR, Expressing, Reverse Transcription Polymerase Chain Reaction, Biomarker Discovery, Positive Control, Sequencing, Fluorescence, In Situ Hybridization

CircATXN2 knockdown alleviates hypoxia-induced PASMC proliferation and migration. PASMCs were transfected with a negative control siRNA (si-NC) or an siRNA targeting circATXN2 (si-circATXN2) for 24 h. Cells were then exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2) for an additional 24 h. A Viability measured by Cell Count Kit-8 (CCK-8) assays with transfected with si-circATXN2 ( n = 5) B , E Representative images ( B ) and quantification ( E ) of cell proliferation assessed by EdU incorporation. EdU-positive (proliferating) cells are green; nuclei are counterstained with DAPI (blue) ( n = 6). Scale bar: 100 µm. C , F Representative images ( C ) and quantification ( F ) of cell migration assessed by a wound healing assay. Images were captured at 0 h and 24 h post-scratch ( n = 5). Scale bar: 100 µm. D , G Representative images ( D ) and quantification ( G ) of cell migration assessed by a Transwell assay. Migrated cells were stained with crystal violet ( n = 5). Scale bar: 50 µm. All data are presented as the mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey's post-hoc test. * P < 0.05, **P < 0.01, ***P < 0.001, ns , not significant

Journal: Respiratory Research

Article Title: CircATXN2 exacerbates pulmonary arterial hypertension by modulating the miR-138-5p/SMURF1 axis

doi: 10.1186/s12931-026-03647-w

Figure Lengend Snippet: CircATXN2 knockdown alleviates hypoxia-induced PASMC proliferation and migration. PASMCs were transfected with a negative control siRNA (si-NC) or an siRNA targeting circATXN2 (si-circATXN2) for 24 h. Cells were then exposed to normoxia (Nor) or hypoxia (Hyp, 3% O2) for an additional 24 h. A Viability measured by Cell Count Kit-8 (CCK-8) assays with transfected with si-circATXN2 ( n = 5) B , E Representative images ( B ) and quantification ( E ) of cell proliferation assessed by EdU incorporation. EdU-positive (proliferating) cells are green; nuclei are counterstained with DAPI (blue) ( n = 6). Scale bar: 100 µm. C , F Representative images ( C ) and quantification ( F ) of cell migration assessed by a wound healing assay. Images were captured at 0 h and 24 h post-scratch ( n = 5). Scale bar: 100 µm. D , G Representative images ( D ) and quantification ( G ) of cell migration assessed by a Transwell assay. Migrated cells were stained with crystal violet ( n = 5). Scale bar: 50 µm. All data are presented as the mean ± SEM. Statistical significance was determined by one-way ANOVA followed by Tukey's post-hoc test. * P < 0.05, **P < 0.01, ***P < 0.001, ns , not significant

Article Snippet: After washing with PBS, the sections were incubated with a Cy3-conjugated anti-rabbit at RT for 1 h, followed by labeling the cell nuclei with DAPI (Servicebio).

Techniques: Knockdown, Migration, Transfection, Negative Control, Cell Characterization, CCK-8 Assay, Wound Healing Assay, Transwell Assay, Staining

circATXN2 acting as a miR-138-5p sponge. A RNA Immunoprecipitation (RIP) for AGO2. qRT-PCR shows significant enrichment of circATXN2 in AGO2 pulldowns compared to IgG controls in PASMCs ( n = 3). B Venn diagram of predicted miRNA targets for circATXN2 from miRanda, TargetScan, and RNAhybrid, identifying miR-138-5p as a top candidate. C RNA pulldown assay using biotinylated miR-138-5p or other candidate miRNAs identified in (B). qRT-PCR analysis shows specific and significant enrichment of circATXN2 only with the miR-138-5p probe ( n = 3). D Schematic of circATXN2 (318 nt) showing the 6 predicted binding sites for miR-138-5p. E Co-localization of circATXN2 (red) and miR-138-5p (green) in PASMCs via FISH assays, demonstrating co-localization in the cytoplasm. Nuclei are counterstained with DAPI (blue). Scale bar: 50 µm. F , G qRT-PCR analysis of miR-138-5p levels in PASMCs following (F) knockdown of circATXN2 (si-circATXN2) or (G) overexpression of circATXN2 (oe-circATXN2), demonstrating reciprocal regulation ( n = 3). H-M Functional rescue experiments. PASMCs were co-transfected with a miR-138-5p mimic or negative control (miR-NC), along with an overexpression vector for circATXN2 (oe-circATXN2) or its control (oe-NC). CCK-8 viability assay ( n = 5) (H). Representative images (I) and quantification (K) of EdU proliferation assay ( n = 3). Scale bar: 100 µm. Representative images (J) and quantification (M) of Transwell migration assay ( n = 3). Scale bar: 50 µm. Quantification of wound healing migration assay ( n = 3) (L). The miR-138-5p mimic reversed the pro-proliferative and pro-migratory effects of circATXN2 overexpression. All data are presented as the mean ± SEM. Statistical significance was determined using a two-tailed Student's t-test (for A, C, F, G) or one-way ANOVA followed by Tukey's post-hoc test (for H, K, L, M). * P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns , not significant

Journal: Respiratory Research

Article Title: CircATXN2 exacerbates pulmonary arterial hypertension by modulating the miR-138-5p/SMURF1 axis

doi: 10.1186/s12931-026-03647-w

Figure Lengend Snippet: circATXN2 acting as a miR-138-5p sponge. A RNA Immunoprecipitation (RIP) for AGO2. qRT-PCR shows significant enrichment of circATXN2 in AGO2 pulldowns compared to IgG controls in PASMCs ( n = 3). B Venn diagram of predicted miRNA targets for circATXN2 from miRanda, TargetScan, and RNAhybrid, identifying miR-138-5p as a top candidate. C RNA pulldown assay using biotinylated miR-138-5p or other candidate miRNAs identified in (B). qRT-PCR analysis shows specific and significant enrichment of circATXN2 only with the miR-138-5p probe ( n = 3). D Schematic of circATXN2 (318 nt) showing the 6 predicted binding sites for miR-138-5p. E Co-localization of circATXN2 (red) and miR-138-5p (green) in PASMCs via FISH assays, demonstrating co-localization in the cytoplasm. Nuclei are counterstained with DAPI (blue). Scale bar: 50 µm. F , G qRT-PCR analysis of miR-138-5p levels in PASMCs following (F) knockdown of circATXN2 (si-circATXN2) or (G) overexpression of circATXN2 (oe-circATXN2), demonstrating reciprocal regulation ( n = 3). H-M Functional rescue experiments. PASMCs were co-transfected with a miR-138-5p mimic or negative control (miR-NC), along with an overexpression vector for circATXN2 (oe-circATXN2) or its control (oe-NC). CCK-8 viability assay ( n = 5) (H). Representative images (I) and quantification (K) of EdU proliferation assay ( n = 3). Scale bar: 100 µm. Representative images (J) and quantification (M) of Transwell migration assay ( n = 3). Scale bar: 50 µm. Quantification of wound healing migration assay ( n = 3) (L). The miR-138-5p mimic reversed the pro-proliferative and pro-migratory effects of circATXN2 overexpression. All data are presented as the mean ± SEM. Statistical significance was determined using a two-tailed Student's t-test (for A, C, F, G) or one-way ANOVA followed by Tukey's post-hoc test (for H, K, L, M). * P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns , not significant

Article Snippet: After washing with PBS, the sections were incubated with a Cy3-conjugated anti-rabbit at RT for 1 h, followed by labeling the cell nuclei with DAPI (Servicebio).

Techniques: RNA Immunoprecipitation, Quantitative RT-PCR, Binding Assay, Knockdown, Over Expression, Functional Assay, Transfection, Negative Control, Plasmid Preparation, Control, CCK-8 Assay, Viability Assay, Proliferation Assay, Transwell Migration Assay, Migration, Two Tailed Test

Reducing circATXN2 in SMCs attenuated the severity of PAH via miR-138-5p/SMURF1 axis. A Immunofluorescence staining of pulmonary arteries confirming SMC-specific AAV9 transduction. GFP (AAV9, green) co-localizes with the SMC marker α-SMA (red). Nuclei were counterstained with DAPI (blue). Scale bar: 100 µm. B qRT-PCR analysis of circATXN2 expression in lung tissue from mice injected with AAV9-si-NC or AAV9-si-circATXN2, confirming successful knockdown ( n = 6) . C Quantification of Right Ventricular Systolic Pressure (RVSP) in the four treatment groups ( n = 6). D , E Echocardiographic measurements of AT/ET ratio (D) and PAVTI (E) in the four treatment groups ( n = 6). F , G Quantification (F) and Hematoxylin and Eosin (H&E) staining (G) of pulmonary arterioles, showing reduced medial wall thickening in the AAV9-si-circATXN2-treated hypoxia group ( n = 6). Scale bar: 50 µm. H Western blot analysis of SMURF1 protein expression in lung lysates from the four treatment groups. β-actin was used as a loading control ( n = 6). I To validate the in vivo role of circATXN2, SMC-specific knockdown was achieved using AAV9-si-circATXN2 in 6-week-old Tagln-Cre mice. As shown in the schematic, mice were injected via the tail vein. After a two-week infection period, mice were exposed to normoxia (21% FiO 2 ) or chronic hypoxia (10% FiO 2 ) and weekly subcutaneous semaxanib (SU5416, 20 mg/kg/week) injections for 4 weeks to induce PAH. All data are presented as the mean ± SEM. Statistical significance was determined using a two-tailed Student's t-test (for B) or two-way ANOVA followed by Tukey's post-hoc test (for C-F). * P < 0.05, **P < 0.01, ns , not significant

Journal: Respiratory Research

Article Title: CircATXN2 exacerbates pulmonary arterial hypertension by modulating the miR-138-5p/SMURF1 axis

doi: 10.1186/s12931-026-03647-w

Figure Lengend Snippet: Reducing circATXN2 in SMCs attenuated the severity of PAH via miR-138-5p/SMURF1 axis. A Immunofluorescence staining of pulmonary arteries confirming SMC-specific AAV9 transduction. GFP (AAV9, green) co-localizes with the SMC marker α-SMA (red). Nuclei were counterstained with DAPI (blue). Scale bar: 100 µm. B qRT-PCR analysis of circATXN2 expression in lung tissue from mice injected with AAV9-si-NC or AAV9-si-circATXN2, confirming successful knockdown ( n = 6) . C Quantification of Right Ventricular Systolic Pressure (RVSP) in the four treatment groups ( n = 6). D , E Echocardiographic measurements of AT/ET ratio (D) and PAVTI (E) in the four treatment groups ( n = 6). F , G Quantification (F) and Hematoxylin and Eosin (H&E) staining (G) of pulmonary arterioles, showing reduced medial wall thickening in the AAV9-si-circATXN2-treated hypoxia group ( n = 6). Scale bar: 50 µm. H Western blot analysis of SMURF1 protein expression in lung lysates from the four treatment groups. β-actin was used as a loading control ( n = 6). I To validate the in vivo role of circATXN2, SMC-specific knockdown was achieved using AAV9-si-circATXN2 in 6-week-old Tagln-Cre mice. As shown in the schematic, mice were injected via the tail vein. After a two-week infection period, mice were exposed to normoxia (21% FiO 2 ) or chronic hypoxia (10% FiO 2 ) and weekly subcutaneous semaxanib (SU5416, 20 mg/kg/week) injections for 4 weeks to induce PAH. All data are presented as the mean ± SEM. Statistical significance was determined using a two-tailed Student's t-test (for B) or two-way ANOVA followed by Tukey's post-hoc test (for C-F). * P < 0.05, **P < 0.01, ns , not significant

Article Snippet: After washing with PBS, the sections were incubated with a Cy3-conjugated anti-rabbit at RT for 1 h, followed by labeling the cell nuclei with DAPI (Servicebio).

Techniques: Immunofluorescence, Staining, Transduction, Marker, Quantitative RT-PCR, Expressing, Injection, Knockdown, Western Blot, Control, In Vivo, Infection, Two Tailed Test